Kolibri revolutionises the way we grow cells at scale using acoustic waves. Cell culture and engineering remains the blocking point to scale up and make advanced therapeutics, such as cell and gene therapies, affordable and accessible, with production costs as high as $3.5M/patient. To that end, we have developed a new and unique way to grow mammalian cells using acoustic waves, in other words: music. Showing 100x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development and manufacturing unlock patient access to these promising therapies.